Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-28 Sale | 2024-03-29 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.97 | $219,400 | 948,311 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,309 | 968,311 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 30,000 | $12.79 | $383,550 | 993,311 (Indirect Direct) | View |
| 2023-12-29 Sale | 2024-01-02 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $13.38 | $334,500 | 1,023,311 (Indirect Direct) | View |
| 2023-11-30 Sale | 2023-12-01 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.57 | $314,250 | 1,048,311 (Indirect Direct) | View |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 8,181 | $14.39 | $117,740 | 1,073,311 (Indirect Direct) | View |
| 2023-10-31 Sale | 2023-11-02 8:50 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 30,000 | $12.65 | $379,450 | 1,065,742 (Indirect Direct) | View |
| 2023-09-29 Sale | 2023-10-03 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,250 | 1,095,742 (Indirect Direct) | View |
| 2023-08-31 Sale | 2023-09-05 9:08 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $10.26 | $256,600 | 1,120,742 (Indirect Direct) | View |
| 2023-08-16 Sale(A) | 2023-09-05 4:05 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $10.14 | $152,100 | 1,023,714 (Direct) | View |
| 2023-08-16 Sale | 2023-08-17 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $10.14 | $152,100 | 1,145,742 (Indirect Direct) | View |
| 2023-06-08 Sale | 2023-06-09 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 10,000 | $6.3 | $63,000 | 1,160,742 (Indirect Direct) | View |
| 2023-06-05 Sale | 2023-06-07 9:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 10,000 | $6.17 | $61,700 | 1,170,742 (Indirect Direct) | View |
| 2021-11-29 Sale | 2021-12-01 5:34 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 400 | $24.76 | $9,904 | 1,173,174 (Indirect Direct) | View |
| 2021-10-19 Sale | 2021-10-21 4:33 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $27.98 | $335,794 | 1,173,574 (Indirect Direct) | View |
| 2021-09-20 Sale | 2021-09-21 6:19 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $26.3 | $315,600 | 1,185,574 (Indirect Direct) | View |
| 2021-08-19 Sale | 2021-08-20 9:14 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $24.97 | $299,640 | 1,197,574 (Indirect Direct) | View |
| 2021-07-19 Sale | 2021-07-21 5:29 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $25.1 | $301,258 | 1,209,574 (Indirect Direct) | View |
| 2021-06-18 Sale | 2021-06-21 7:05 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 12,000 | $24.8 | $297,626 | 1,099,546 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,750 | $0 | 1,073,311 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:23 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Research Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:10 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus CHIEF TECHNOLOGY OFFICER | 104,500 | $0 | 104,500 (Direct) | View |
| 2020-11-23 Conversion | 2020-11-23 4:31 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 193,402 | $0 | 1,233,574 (Direct) | View |
| 2020-11-18 Option Award(A) | 2020-11-20 6:42 pm | N/A 2030-11-17 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 1,076 | $0 | 1,076 (Indirect) | View |
| 2020-09-12 Option Award | 2020-11-19 6:43 pm | N/A 2030-09-11 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 550,671 | $0 | 1,447,371 (Direct) | View |
Ownership | 2020-11-18 6:19 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Chief Technology Officer | 0 | $0 | 1,461,433 (Direct) | View |